| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2011 | US7927600 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 04/19/2011 | US7927589 Non-immunognic polyethylene glycol conjugated therapeutic uricase for use in treatment of kidney and inflammatory disorders |
| 04/19/2011 | US7927588 Skin dressings containing oxidoreductase enzyme |
| 04/19/2011 | US7927583 Receptor based antagonists and methods of making and using |
| 04/19/2011 | US7927580 Identifying new immunomodulatory chemical entities (NICE); reacting a candidate NICE with a Tat SH3 binding domain, identifying the bound candidate NICE and determining whether it induces monocytes to differentiate into dendritic cells (DC) or regulatory macrophages (AReg); drug screening; immunotherapy |
| 04/19/2011 | CA2596241C Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/19/2011 | CA2515322C Leukocyte stimulating peptides |
| 04/19/2011 | CA2458452C Gnrh agonist combination drugs |
| 04/19/2011 | CA2450946C Use of branched-chain fatty acids and derivatives thereof for the treatment of pain |
| 04/19/2011 | CA2447751C Dental restorative materials |
| 04/19/2011 | CA2447703C Methods for proliferating terminal differentiated cells and recombinant vectors therefor |
| 04/19/2011 | CA2445048C Preparations containing afamin for treating oxidative stress-induced neurogenerative disease |
| 04/19/2011 | CA2440557C Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
| 04/19/2011 | CA2421258C Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 04/19/2011 | CA2399187C Kahalalide compounds |
| 04/19/2011 | CA2394430C A calcium absorption enhancing agent and a method for producing it |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2370289C Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 04/19/2011 | CA2362496C Polypeptide variants with increased heparin-binding ability |
| 04/19/2011 | CA2320962C Novel mixed amylin activity compounds |
| 04/19/2011 | CA2320429C Antimicrobial peptides and derived metapeptides |
| 04/19/2011 | CA2319599C Delivery of immunogenic molecules via hbsag particles |
| 04/19/2011 | CA2291963C Tumor necrosis factor receptor-derived peptide analogues |
| 04/19/2011 | CA2226301C Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 04/19/2011 | CA2220116C Dna encoding glutamate gated chloride channels |
| 04/17/2011 | CA2776132A1 Method of treating cravings by administration of nerve growth factor |
| 04/14/2011 | WO2011044499A2 Enterotoxigenic e. coli fusion protein vaccines |
| 04/14/2011 | WO2011044452A2 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences |
| 04/14/2011 | WO2011044443A2 Matricryptic ecm peptides for tissue reconstruction |
| 04/14/2011 | WO2011044381A1 Pain relief composition, system and method |
| 04/14/2011 | WO2011044374A1 Capcna peptide therapeutics for cancer |
| 04/14/2011 | WO2011044367A1 Methods and compositions for skin regeneration |
| 04/14/2011 | WO2011044329A2 Devices, systems and methods for cell modification |
| 04/14/2011 | WO2011044096A1 Peptide-based peroxidase inhibitors and methods of using same |
| 04/14/2011 | WO2011044089A2 Methods of treating depression and other related diseases |
| 04/14/2011 | WO2011044082A2 Compositions and methods for inhibiting madcam |
| 04/14/2011 | WO2011044044A1 Methods for the prevention or treatment of heart failure |
| 04/14/2011 | WO2011043858A1 Method of treating cravings by administration of nerve growth factor |
| 04/14/2011 | WO2011043809A2 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 04/14/2011 | WO2011043788A2 Daptomycin for multiple sclerosis |
| 04/14/2011 | WO2011043740A1 Peptides for inhibition of myd88-dependent signaling pathways |
| 04/14/2011 | WO2011043739A1 Methods and compositions for maintenance of a functional wound |
| 04/14/2011 | WO2011043696A1 Process for preparing an iga1 protease from a culture of n. меningiтidis serogroup a and polyvalent vaccine preparation for the prophylaxis of an infection caused by bacteria of n. меningiтidis serogroups а and в |
| 04/14/2011 | WO2011042688A1 Pharmaceutical preparation comprising recombinant hcg |
| 04/14/2011 | WO2011042548A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 04/14/2011 | WO2011042501A2 The intestine and muscle recovery |
| 04/14/2011 | WO2011041870A1 Non-steroidal anti-inflammatory drugs coadministered with nitric oxide amino acid ester compounds as prophylaxis in hypertensive patients |
| 04/14/2011 | WO2011041865A1 Pharmaceutical composition containin an apitoxin fraction and use thereof |
| 04/14/2011 | WO2011041847A1 Chaperonin 10 variants |
| 04/14/2011 | WO2011020866A3 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 04/14/2011 | WO2011020596A3 Cyclosporine derivatives |
| 04/14/2011 | WO2011015634A3 Controlled release formulations of lipocalin muteins |
| 04/14/2011 | WO2011000516A3 Gamma globin therapy |
| 04/14/2011 | WO2010150242A3 Immunogenic streptococcus pneumoniae peptides and peptide-multimers |
| 04/14/2011 | WO2010141097A3 Pegylated human apoa-1 and process for production thereof |
| 04/14/2011 | WO2010138379A3 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin |
| 04/14/2011 | WO2010120649A3 Composition and use of n-alpha-methylhistamine dihydrochloride for the reduction of oxygen radical formation |
| 04/14/2011 | US20110088106 Compositions and methods for mediating cell cycle progression |
| 04/14/2011 | US20110087195 Transmucosal drug delivery device and method including microneedles |
| 04/14/2011 | US20110087192 Transmucosal drug delivery device and method including chemical permeation enhancers |
| 04/14/2011 | US20110087155 Transmucosal drug delivery device and method including electrically-actuated permeation enhancement |
| 04/14/2011 | US20110087007 Cytokine-Like Proteins |
| 04/14/2011 | US20110087006 DNA Sequence Encoding a Retinoic Acid Regulated Protein |
| 04/14/2011 | US20110087002 Methods for Cyclizing Synthetic Polymers |
| 04/14/2011 | US20110086809 Enteral Administration Of Arginine-Glutamine Dipeptide To Support Retinal, Intestinal, Or Nervous System Development |
| 04/14/2011 | US20110086808 Modified therapeutic agents |
| 04/14/2011 | US20110086807 Fibromodulin formulation for reducing corneal scarring |
| 04/14/2011 | US20110086806 Polypeptides that Bind IL-23R |
| 04/14/2011 | US20110086805 In vitro method for diagnosing skin cancer |
| 04/14/2011 | US20110086804 Treatment of parkinson's disease |
| 04/14/2011 | US20110086803 Peptides containing tryptophan |
| 04/14/2011 | US20110086802 Methods to increase permeability of corneal epithelium and destabilize stromal collagen fibril network |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/14/2011 | US20110086800 Screening method for predicting susceptibility to breast cancer |
| 04/14/2011 | US20110086799 GnRH II Analogs and Uses Thereof in the Immune System |
| 04/14/2011 | US20110086798 Erythropoietin compositions |
| 04/14/2011 | US20110086797 Control of spore germination |
| 04/14/2011 | US20110086796 Methods for predicting the development and resolution of acute respiratory distress syndrome |
| 04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
| 04/14/2011 | US20110086794 Delivery agent |
| 04/14/2011 | US20110086105 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation |
| 04/14/2011 | US20110086104 Residual solvent extraction method and microparticles produced thereby |
| 04/14/2011 | US20110086101 Dispersinb, 5-Fluorouracil, Deoxyribonuclease I and Proteinase K-Based Antibiofilm Compositions and Uses Thereof |
| 04/14/2011 | US20110086100 Polyethylene Glycol Aerogels for Targeted Delivery of Pharmaceutical Drubs |
| 04/14/2011 | US20110086091 Stable crystal modifications of dopc |
| 04/14/2011 | US20110086089 Use of p27kip1 for the prevention and treatment of heart failure |
| 04/14/2011 | US20110086077 Silicone hydrogels for tissue adhesives and tissue dressing applications |
| 04/14/2011 | US20110086073 NANOMETER-SIZED PRODRUGS OF NSAIDs |
| 04/14/2011 | US20110086072 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/14/2011 | US20110086064 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 04/14/2011 | US20110086057 OX40R Binding Agents |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086049 Receptor Modulators |
| 04/14/2011 | US20110086048 Detection of human immunodeficiency virus co-receptor tropism in aviremic subjects |
| 04/14/2011 | US20110086044 Compositions and Methods to Inhibit HPV Infection |
| 04/14/2011 | US20110086043 STAT5a AND ITS FUNCTIONAL TUMOR SUPPRESSOR ANALOGS FOR TREATMENT OF MALIGNANCIES EXPRESSING NPM/ALK AND OTHER ONCOGENIC KINASES |
| 04/14/2011 | US20110086036 Composition comprising vlp and amyloid beta peptide |
| 04/14/2011 | US20110086035 Immunotherapeutic methods and molecules |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |